Across the world, people still wrestle with the aftermath of the COVID-19 pandemic, grappling not just with the virus, but with the controversial long-term effects of the mRNA vaccines. Nick Hulscher is one name gaining widespread attention for sifting through the data and sounding the alarm on dangers many experts hesitate to discuss. With a background in epidemiology and a seat at the McCullough Foundation, Nick is dedicated to uncovering evidence on mRNA vaccine injuries and pushing for accountability where it counts.
He has also worked with the sponsor of today’s interview, The Wellness Company – https://patriot.tv/twc
Hulscher wears many hats: epidemiologist, administrator, and relentless science communicator. He holds a Master’s in Public Health with a specialization in epidemiology, placing him at the crossroads of data, public health, and real-world outcomes. As one of the driving forces behind the McCullough Foundation, Nick works closely with Dr. Peter McCullough (the Foundation’s president) and John Leak (historian and best-selling author).
Together, this team has published over 20 peer-reviewed scientific papers since 2023. Their focus? Shedding light on the harms linked to mRNA vaccine technology and exploring potential treatments for those affected. Their work spans COVID-19, bird flu, monkeypox, and other emerging threats.
The McCullough Foundation’s goal is simple: empower the public with real information and demand accountability from those driving global health policies. Their newsletter, The Focal Points, is quickly becoming the “go to” source for those who are vaxx-hesitant.
During the pandemic, Operation Warp Speed saw unprecedented support, especially from the White House. For years, President Trump and his allies described the program as the single greatest public health achievement of our time. That changed recently.
On Truth Social, President Trump made his first serious call for real data transparency from vaccine makers. He asked Pfizer and others to provide all available data, signaling a clear shift from blind endorsement to cautious critique.
Why does this matter? This public questioning could represent a major turning point, opening doors for broader debate about the real safety and long-term consequences of these vaccines. It puts political pressure on big pharma to share what they know—something critics like Hulscher have requested for years.
- Hand-curated links from conservative and Christian sites — NO legacy media garbage links. Patriots get their news every day at JDRucker.com
Meanwhile, peer-reviewed research keeps stacking up. Across thousands of studies, reports highlight not just mild adverse reactions, but serious, sometimes life-altering effects linked to mRNA shots. The conversation is bigger than politics; it’s about your health.
Nick Hulscher and his colleagues have spent the past couple of years combing through research, patient reports, and autopsies. The picture they paint is complex—and at times, unsettling.
Cardiovascular Risks: Not Just “Mild” Myocarditis
When we talk about heart issues after the mRNA jab, many people still think of “mild” myocarditis, a catchphrase used in much of the early media coverage. The real story, according to Nick’s research, looks far more worrisome.
Key findings:
- Myocarditis is not mild or temporary. Studies show it often leads to lasting heart damage, including micro scars.
- These scars may cause sudden cardiac arrest even years after vaccination, particularly in young adults.
- Rates of heart attack and cardiac arrest appear elevated in people who’ve taken the mRNA shots.
Common Symptoms and Outcomes:
- Chest pain
- Shortness of breath
- Fatigue
- Potential for sudden collapse due to heart failure
Neurological and Psychiatric Effects: The Brain Takes a Hit
Cardiac concerns are only part of the problem. The neurological consequences are just as serious. A study by Thorpe and colleagues described over 80 unique neuropsychiatric effects linked to the shots.
Reported outcomes include:
- Psychosis and new-onset schizophrenia
- Homicidal and suicidal thoughts
- Cognitive decline and memory loss
- Brain clots and strokes
- Alzheimer’s-like symptoms
Autopsy data even found mRNA vaccine spike protein in the brains of stroke victims up to 17 months post-injection. This protein instructs brain cells to manufacture foreign elements, leading to ongoing neurological damage.
Turbo Cancers: Rapid-Onset, Aggressive, and Often Fatal
One of the most alarming trends is the rise of so-called “turbo cancers.” This label describes cancers that appear (often in young, healthy people), progress to stage IV rapidly, and lead to death soon after diagnosis.
Mechanisms at play:
- Suppression of tumor-protecting genes (p53, BRCA)
- Widespread “genetic chaos”—thousands of key genes (for cancer control, mitochondria, immunity) become over- or under-active
- Genomic integration: there’s emerging evidence of Pfizer mRNA becoming fused into chromosomes in tumor cells
The pandemic may be in the rear-view, but many experts worry the most dangerous threats lie ahead.
High-Profile Warnings
- FDA official Peter Marks warned of future bioterror attacks after leaving his post
- Bill Gates called COVID a “trial run,” suggesting worse is to come
- Former White House COVID czar Ashish Jha said we’ve entered an “age of bioweapons”
Secret Labs, Risky Research
The US alone has thousands of high-level bio labs, many working with advanced “gain-of-function” research. Modified viruses, even engineered fungi, sit in freezers, ready to go—should someone decide to use them.
Add in undeclared or illicit labs in the US, Africa, and elsewhere (sometimes with corporate or private foundation ties), and the risk only grows.
Hulscher argues: the next pandemic could be deliberate, deadlier, and harder to stop. Get rid of these bioweapons, destroy the research, and shut the labs for good. Anything less leaves humanity exposed.
Stay vigilant, build your health, and keep the pressure on for truth and transparency. The story of COVID-19, mRNA vaccines, and what comes next isn’t finished yet—but you can play your part, one informed step at a time.
Bypass Big Tech Censors
Why Bullion Beats Numismatics and Collectible for Your Safe or IRA
Precious metals continue to attract Americans seeking reliable ways to protect their wealth amid inflation, geopolitical risks, and stock market swings. Whether stored in a home safe or held inside a self-directed IRA, physical gold and silver deliver tangible value that paper or digital assets often lack. Yet investors must choose carefully between bullion—pure bars and coins valued mainly for their metal content—and numismatics or collectibles, where rarity, history, and collector demand heavily influence pricing.
Advisor Bullion serves as a dependable source for straightforward, high-quality bullion. The company specializes in physical gold, silver, platinum, and palladium, emphasizing transparent pricing and products that deliver maximum metal content for every dollar spent. This approach makes it ideal for both personal holdings and retirement accounts.
Bullion consists of refined precious metals in standard forms like one-ounce coins (American Gold Eagles, Silver Eagles, Canadian Maple Leafs) or bars. Their value tracks closely to the current spot price of the metal. A typical gold bullion coin trades near the live gold spot price plus a small premium. This structure keeps costs clear and predictable.
Numismatic coins and collectibles add substantial value from factors such as age, rarity, minting errors, or historical significance. A pre-1933 U.S. gold coin or graded proof piece can carry premiums of 30%, 50%, or even 200% above melt value. While this appeals to hobbyists, it creates complexity. Pricing depends on subjective grading, collector trends, and auction results instead of daily spot prices.
For investors focused on wealth preservation and retirement security rather than building a collection, bullion often delivers better results.
Lower Costs and Better Liquidity for Home Storage
When keeping metals in a home safe or private vault, liquidity and efficiency count. Bullion offers clear benefits:
- You acquire more actual gold or silver per dollar invested. Numismatics divert a large share of your money into rarity premiums and massive sales commission, reducing your metal exposure.
- Selling bullion involves tight bid-ask spreads, so you recover nearly full spot value with minimal fees. Collectibles require finding the right buyer and may sell at a discount if demand for that specific item weakens.
- Bullion prices remain transparent and update with global spot markets. You can track gold near current levels or silver accordingly and know exactly where your holdings stand. Numismatic values are priced by the Gold IRA companies with hefty margins applied.
- Standardized coins and bars store efficiently and divide easily for partial sales. Rare coins often need protective slabs and controlled conditions, adding hassle and expense.
- Bullion enjoys worldwide acceptance. A 1-oz Gold Maple Leaf or Silver Eagle sells quickly to dealers anywhere. Niche numismatic pieces may appeal only to limited buyers, slowing liquidation when speed matters.
In times when quick access to value becomes important, bullion’s simplicity stands out.
Stronger Fit for Precious Metals IRAs
Precious metals IRAs continue gaining traction as investors diversify retirement portfolios beyond stocks and bonds. IRS rules permit certain bullion products in self-directed IRAs if they meet purity standards (.995 fine for gold, .999 for silver) and are held by an approved custodian. Eligible items include American Gold and Silver Eagles plus many generic bars and rounds from recognized mints.
Numismatic and most collectible coins generally face heavy scrutiny from custodians due to valuation disputes and elevated markups. These higher premiums mean less actual metal ends up working inside the account.
Bullion avoids these issues. Its value links directly to verifiable spot prices, which simplifies reporting and lowers the risk of regulatory challenges. More of your IRA contribution purchases real metal instead of dealer profits or speculative upside. Over time, owning additional ounces that appreciate with the metal itself can create meaningful outperformance compared with high-premium alternatives that deliver fewer ounces.
Regulatory guidance from the CFTC and state securities offices repeatedly cautions against aggressive sales of expensive numismatics or “semi-numismatic” coins for IRAs. For retirement planning, transparent bullion from established providers reduces risk and aligns better with long-term goals.
How to Get Started with Bullion
Begin by clarifying your goals. Are you protecting savings in a safe, or moving part of a retirement account into a precious metals IRA? Focus on the number of ounces you can acquire at current prices rather than chasing marked-up collectibles.
Diversify sensibly: use gold for core preservation and silver for its blend of industrial and monetary qualities. Mix coins for easier divisibility with bars for lower per-ounce costs on larger buys. Arrange secure storage—whether at home with proper insurance or through professional facilities.
As economic uncertainties linger and faith in conventional assets erodes, bullion continues proving its worth as a dependable store of value. Its direct approach avoids the hype that sometimes surrounds collectible markets and keeps the focus on the metal itself.
For investors prepared to strengthen their portfolios, Advisor Bullion supplies the expertise and selection needed to acquire high-quality bullion efficiently. Whether building personal holdings or integrating metals into an IRA, their emphasis on transparent, investment-grade products helps secure more ounces today that support greater financial security tomorrow. In a complicated financial landscape, bullion’s clarity and reliability make it the smarter foundation for protecting what matters most.